Apotex Corp. announced April 12 the company’s release of Paclitaxel protein-bound particles for injection (albumin-bound), a generic version of Abraxane in the United States.
Cranbury, New Jersey-based Rafael Pharmaceuticals reported disappointing results from two Phase III clinical trials evaluating the safety and efficacy of the cancer metabolism drug CPI-613 (devimistat) when combined with modified FOLFIRINOX (mFFX) as a first-line therapy.
Chemo Drug Potentially More Potent than Remdesivir Against Coronavirus
Antibiotics, Chemotherapeutics, Chemotherapy, China, Clinical Studies, Clinical Trials, Coronavirus Disease 2019 (COVID-19), Drug screenings, Peripheral T-Cell Lymphoma (PTCL), PLOS Computational Biology, R&D, Remdesivir, Researchers, RNA, SARS-CoV-2 virus, TherapeuticsThe chemotherapy pralatrexate and the antibiotic azithromycin were successful at preventing replication of the SARS-CoV-2 virus, according to research with Shenzhen Institutes of Advanced Technology in China.